United Biomedical unitedbiomedical.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

United Biomedical (UBI) is an international bio/pharmaceutical firm with technology utilizing reverse genomics and synthetic peptide chemistry, coupled with traditional pharmaceutical and therapeutic delivery systems. The company has been built with a corporate culture that strongly emphasizes innovation, with goals to provide products for unmet medical needs. UBI is committed to treating and preventing diseases with unmet needs by directing the immune system. They have designer peptides and mon...Show all

United Biomedical (UBI) is an international bio/pharmaceutical firm with technology utilizing reverse genomics and synthetic peptide chemistry, coupled with traditional pharmaceutical and therapeutic delivery systems. The company has been built with ...Show all

Company (Alive / Active)

Phone: 631-273-2828

Fax: 631-273-1717

25 Davids Drive

Hauppauge, 11788
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
United Biomedical $0M Nov 30, 2018
See all 24 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related United Biomedical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

MacuSight

Palo Alto, California, United States
Alive / ActiveMacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of th...Show allLogin to see details

Sequana Therapeutics

La Jolla, California, United States
AcquiredSequana provides research and development for gene discovery, characterization, and identification for drug discovery.Login to see details
See all 24 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Designer peptide-based pcv2 vaccine Jul 08, 2010 Apr 03, 2018 Patent
Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type Mar 15, 2013 Aug 11, 2015 Patent
Immunogenic peptide composition for the prevention and treatment of alzheimer's disease Dec 03, 2010 Jul 31, 2012 Patent
Stabilized synthetic immunogen delivery system Feb 14, 2002 Jan 03, 2012 Patent
Stabilized synthetic immunogen delivery system May 21, 2003 Dec 27, 2011 Patent
See all 14 patents